Section Arrow
ZOM.NYSE-M
- Zomedica Corp
(Financial Status)
Quotes are at least 15-min delayed:2024/05/03 12:53 EDT
Last
 0.14585
+0.00385 (+2.71%)
Day High 
0.1489 
Prev. Close
0.142 
1-M High
0.15 
Volume 
2.98M 
Bid
0.1457
Ask
0.146
Day Low
0.142 
Open
0.142 
1-M Low
0.1223 
Market Cap 
139.15M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.13 
20-SMA 0.14 
50-SMA 0.14 
52-W High 0.245 
52-W Low 0.12 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.04/--
Enterprise Value
140.97M
Balance Sheet
Book Value Per Share
0.24
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
25.19M
Operating Revenue Per Share
0.02
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HSDTHelius Medical Technologies2.7399+0.0799+3.00%-- 
NUWENuwellis0.1754-0.0306-14.85%-- 
PACBPacific Biosciences of California1.86+0.1+5.68%-- 
SINTSiNtx Technologies0.0453-0.0018-3.82%-- 
BFLYButterfly Network1.03+0.1077+11.68%-- 
Quotes are at least 15-min delayed:2024/05/03 12:53 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.